Keywords: transcell, tech, gains, patent, technologies, majority-owned, subsidiary
TRANSCELL TECH GAINS PATENT
Article | 14 March 1994
Transcell Technologies, a majority-owned subsidiary of Interneuron Pharmaceuticals, has been issued a US patent covering key components of Transcell's core ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
